» Articles » PMID: 34297405

Full-length G Glycoprotein Directly Extracted from Rabies Virus with Detergent and then Stabilized by Amphipols in Liquid and Freeze-dried Forms

Overview
Publisher Wiley
Specialty Biochemistry
Date 2021 Jul 23
PMID 34297405
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Pathogen surface antigens are at the forefront of the viral strategy when invading host organisms. These antigens, including membrane proteins (MPs), are broadly targeted by the host immune response. Obtaining these MPs in a soluble and stable form constitutes a real challenge, regardless of the application purposes (e.g. quantification/characterization assays, diagnosis, and preventive and curative strategies). A rapid process to obtain a native-like antigen by solubilization of a full-length MP directly from a pathogen is reported herein. Rabies virus (RABV) was used as a model for this demonstration and its full-length G glycoprotein (RABV-G) was stabilized with amphipathic polymers, named amphipols (APols). The stability of RABV-G trapped in APol A8-35 (RABV-G/A8-35) was evaluated under different stress conditions (temperature, agitation, and light exposure). RABV-G/A8-35 in liquid form exhibited higher unfolding temperature (+6°C) than in detergent and was demonstrated to be antigenically stable over 1 month at 5°C and 25°C. Kinetic modeling of antigenicity data predicted antigenic stability of RABV-G/A8-35 in a solution of up to 1 year at 5°C. The RABV-G/A8-35 complex formulated in an optimized buffer composition and subsequently freeze-dried displayed long-term stability for 2-years at 5, 25, and 37°C. This study reports for the first time that a natural full-length MP extracted from a virus, complexed to APols and subsequently freeze-dried, displayed long-term antigenic stability, without requiring storage under refrigerated conditions.

Citing Articles

Formulation development of a stable influenza recombinant neuraminidase vaccine candidate.

Li B, Ustyugova I, Szymkowicz L, Zhu S, Ming M, Fung K Hum Vaccin Immunother. 2024; 20(1):2304393.

PMID: 38497413 PMC: 10950269. DOI: 10.1080/21645515.2024.2304393.


Full-length G glycoprotein directly extracted from rabies virus with detergent and then stabilized by amphipols in liquid and freeze-dried forms.

Clenet D, Clavier L, Strobbe B, Le Bon C, Zoonens M, Saulnier A Biotechnol Bioeng. 2021; 118(11):4317-4330.

PMID: 34297405 PMC: 9291542. DOI: 10.1002/bit.27900.

References
1.
Costantino H, Langer R, Klibanov A . Aggregation of a lyophilized pharmaceutical protein, recombinant human albumin: effect of moisture and stabilization by excipients. Biotechnology (N Y). 1995; 13(5):493-6. DOI: 10.1038/nbt0595-493. View

2.
Clenet D . Accurate prediction of vaccine stability under real storage conditions and during temperature excursions. Eur J Pharm Biopharm. 2018; 125:76-84. DOI: 10.1016/j.ejpb.2018.01.005. View

3.
Feinstein H, Tifrea D, Sun G, Popot J, de la Maza L, Cocco M . Long-term stability of a vaccine formulated with the amphipol-trapped major outer membrane protein from Chlamydia trachomatis. J Membr Biol. 2014; 247(9-10):1053-65. PMC: 4198661. DOI: 10.1007/s00232-014-9693-5. View

4.
Qoronfleh M, Hesterberg L, Seefeldt M . Confronting high-throughput protein refolding using high pressure and solution screens. Protein Expr Purif. 2007; 55(2):209-24. DOI: 10.1016/j.pep.2007.05.014. View

5.
Hansen L, Daoussi R, Vervaet C, Remon J, De Beer T . Freeze-drying of live virus vaccines: A review. Vaccine. 2015; 33(42):5507-5519. DOI: 10.1016/j.vaccine.2015.08.085. View